CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS

Company

Telix Pharmaceuticals Ltd

Filed

February 3, 2026

Period of Report

February 2, 2026

Accession Number

0002007191-26-000006